【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Fatty Liver Disease 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Fatty Liver Disease 24
Subjects Recruited Over a Period of Time 25
Prominent Sponsors 26
Top Companies Participating in Fatty Liver Disease Therapeutics Clinical Trials 28
Prominent Drug Comparison 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Merck & Co., Inc. 31
Clinical Trial Overview of Merck & Co., Inc. 31
Sanofi 32
Clinical Trial Overview of Sanofi 32
Galmed International Ltd. 33
Clinical Trial Overview of Galmed International Ltd. 33
Biovil Research Group, LLC 34
Clinical Trial Overview of Biovil Research Group, LLC 34
PharmaKing Co., Ltd. 35
Clinical Trial Overview of PharmaKing Co., Ltd. 35
Zota Health Care Limited 36
Clinical Trial Overview of Zota Health Care Limited 36
VSL Pharmaceuticals, Inc. 37
Clinical Trial Overview of VSL Pharmaceuticals, Inc. 37
Nova Laboratories Ltd 38
Clinical Trial Overview of Nova Laboratories Ltd 38
Parry Nutraceuticals 39
Clinical Trial Overview of Parry Nutraceuticals 39
CD Pharma India Private Ltd. 40
Clinical Trial Overview of CD Pharma India Private Ltd. 40
Intercept Pharmaceuticals, Inc. 41
Clinical Trial Overview of Intercept Pharmaceuticals, Inc. 41
Antipodean Pharmaceuticals, Inc. 42
Clinical Trial Overview of Antipodean Pharmaceuticals, Inc. 42
Lyka Labs Limited 43
Clinical Trial Overview of Lyka Labs Limited 43
GW Pharmaceuticals plc 44
Clinical Trial Overview of GW Pharmaceuticals plc 44
Norgine BV 45
Clinical Trial Overview of Norgine BV 45
Abbott Laboratories 46
Clinical Trial Overview of Abbott Laboratories 46
F. Hoffmann-La Roche Ltd. 47
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 47
Clinical Trial Overview of Top Universities / Institutes / Hospitals 48
Third Military Medical University 48
Clinical Trial Overview of Third Military Medical University 48
Tehran University of Medical Sciences 49
Clinical Trial Overview of Tehran University of Medical Sciences 49
Washington University School of Medicine 50
Clinical Trial Overview of Washington University School of Medicine 50
FUDAN University 51
Clinical Trial Overview of FUDAN University 51
Kanazawa University Graduate School of Medical Sciences 52
Clinical Trial Overview of Kanazawa University Graduate School of Medical Sciences 52
Ziv Medical Center 53
Clinical Trial Overview of Ziv Medical Center 53
Aarhus University 54
Clinical Trial Overview of Aarhus University 54
Osaka City University 55
Clinical Trial Overview of Osaka City University 55
Tabriz University of Medical Sciences 56
Clinical Trial Overview of Tabriz University of Medical Sciences 56
University of California, San Diego 57
Clinical Trial Overview of University of California, San Diego 57
Chinese University of Hong Kong 58
Clinical Trial Overview of Chinese University of Hong Kong 58
Hadassah Medical Organization 59
Clinical Trial Overview of Hadassah Medical Organization 59
University Health Network 60
Clinical Trial Overview of University Health Network 60
Duke University 61
Clinical Trial Overview of Duke University 61
Kyoto University 62
Clinical Trial Overview of Kyoto University 62
Tel-Aviv Sourasky Medical Center 63
Clinical Trial Overview of Tel-Aviv Sourasky Medical Center 63
Imperial College London 64
Clinical Trial Overview of Imperial College London 64
University of Zurich 65
Clinical Trial Overview of University of Zurich 65
Far Eastern Memorial Hospital 66
Clinical Trial Overview of Far Eastern Memorial Hospital 66
The Medical University of Graz 67
Clinical Trial Overview of The Medical University of Graz 67
Five Key Clinical Profiles 68
Appendix 91
Abbreviations 91
Definitions 91
Research Methodology 92
Secondary Research 92
About GlobalData 93
Contact Us 93
Disclaimer 93
Source 94
【レポート販売概要】
■ タイトル：Fatty Liver Disease：グローバル臨床試験レビューH1, 2013■ 英文：Fatty Liver Disease Global Clinical Trials Review, H1, 2013
■ 発行日：2013年1月25日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160108
■ 調査対象地域：グローバル
- 世界主要国における淋疾検査市場2015The report presents a detailed analysis of the Gonorrhea diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Gonorrhea definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Com …
- パラキシレンの世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world paraxylene market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true insigh …
- 世界のサイバーセキュリティー（Cybersecurity）市場動向2013-2023：主な開発プロジェクトThis report discusses the various programmes conducted by key players in the market, by dividing them into the main types of Cybersecurity. The report offers detailed information regarding quantity procured, country/companies supplying the equipment, delivery period and total contract value.
- 乾癬市場：日本の治療薬市場Psoriasis - Japan Drug Forecast and Market Analysis to 2024 Summary Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. Specifically, adult plaque psoriasis, the most common form of Psoriasis, is the focus of this report. Although not life-threatening, Psoriasis causes tremendous morbidity and personal angst for p …
- 自動車ゴム成型品の世界市場：EPDM、天然ゴム、SBRThe automotive rubber molded components market, in terms of value, is projected to grow at a CAGR of 5.20% from 2015 to 2020, to reach a market size of USD 40.5 Billion by 2020. This growth can be attributed to factors such as the increasing adoption of lightweight materials, government regulations, fluctuating oil prices, environmental concerns, limited number of suppliers, and technological adva …
- 世界の小型自動車用OE排気装置市場【2015年1月更新版】This latest just-auto report edition offers a global review of the OE automotive exhaust systems sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE exhaust systems market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their str …
- 世界の不揮発性メモリ（Non-Volatile Memory）市場動向2014 – 2020Non-volatile memory is used to store data even if it is non-powered. Non-volatile memory is used for secondary storage, especially long term storage, as these memory devices do not require continuous power supply for storing information. Because of this, the non-volatile memories are widely used in mission critical applications such as data centers. Although devices which can store information up …
- 世界のネットワーク管理市場：性能モニタリング、IPアドレス管理、 トラフィック管理などCross domain management operations, Software as a Service (SaaS)-based network management and performance service level agreements in cloud monitoring are expected to redefine traditional network. Moreover, increased network complexity, converging technologies and growing implementation of virtualization are expected to transform network technologies, tools and practices and virtual networking ins …
- Avonex (Multiple Sclerosis)：市場予測と分析（～2022）Avonex (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Avonex (Multiple Sclerosis) - Forecast and Market Analysis to 2022”. Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous …
- 世界の主要ウェアラブル技術企業動向2014Wearable technology is the buzzword of 2014. A market that has existed for decades, however now microprocessors and MEMS are finally compact enough for the device category to reach fruition. In an environment heading towards a connected homes paradigm, the next step in our technological evolution is bringing control closer than arm’s reach. Wearables dominated 2014’s CES, with every major OEM cham …
- 再かん流傷害：グローバル臨床試験レビューH1, 2014Reperfusion Injury Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Reperfusion Injury Global Clinical Trials Review, H1, 2014" provides data on the Reperfusion Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Reperfusion Injury. It includes an overview of the trial numbers and their recruitme …
- 微生物検査/臨床微生物学の世界市場予測（～2021）The global clinical microbiology market is projected to reach USD 5.77 Billion by 2021 from USD 3.35 Billion in 2016, growing at a CAGR of 11.5% from 2016 to 2021. Market growth can be attributed to factors such as technological advancements; rising incidence of infectious diseases and growing outbreak of epidemics; growing healthcare expenditure across the world; and increasing funding, research …
- EVコネクターの世界市場予測（～2025年）“Increasing EV sales with demand for EV charging points has driven the demand for EV connectors globally” The global EV connectors market is estimated to grow from USD 30 million in 2018 at a CAGR of 18.44% to reach USD 98 million by 2025. Favorable government policies and support in terms of subsidies and grants, tax rebates for EVs, and EV charging points would drive the growth of EV charging st …
- ヘルスケアサイバーセキュリティの世界市場展望2017-20276According to Stratistics MRC, the Global Healthcare Cyber Security Market is accounted for $6.88 billion in 2017 and is expected to reach $36.88 billion by 2026 growing at a CAGR of 20.5% during the forecast period. Increasing demand for cloud services, and rising cases of healthcare cyber-attacks are the key driving factors for the market growth. However, shortage of trained professionals is hind …
- 神経学的バイオマーカーの世界市場2016-2020About Biomarkers Biomarkers are the indicators considered for identifying specific diseases. They are mainly used for identification of the progress of a particular disease and evaluation of an effective method for drug target identification. The biomarkers specifically involved in the identification of the neurological disorders are called neurological biomarkers. Technavio’s analysts forecast th …
